MedPath

Evaluation of different doses of midazolam for amnesia and sedation in general anesthesia

Phase 2
Conditions
amnesia.
Dissociative amnesia
Registration Number
IRCT201101293468N5
Lead Sponsor
Shahid Sadoughi University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Inclusion Criteria: 1- ASA Class=1,2; 2- Elective outpatient surgical procedure under general anesthesia; 3- age below 60 years; 4- weight between 50-100 kilogram; 5- No visual disturbance; 6- No auditory disturbance; 7- No memory disturbance; 8- No tranqulizer drug consumption. Exclusion criteria: known allergy to study drug.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amnesia. Timepoint: after 4 hours. Method of measurement: events and poster recall.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath